Select for export Lifetime Psychedelic Use and Opioid Use Disorder Severity: Substance-Use Pattern Specific and Mental Health-Dependent Associations in a National Survey Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.addbeh.2026.108652 Copy citation Copy BibTeX PsyArXiv 2025-11-01 Authors unavailable PsyArXiv PREPRINT (not peer reviewed) psilocybin DepressionAddictionObservational Study Observational Study More
Select for export CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYS Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1093/neuonc/noaf201.0244 Copy citation Copy BibTeX Neuro-Oncology 2025-10-31 Richard Drexler, Belgin Yalçın, Rebecca Mancusi, Abigail Rogers, Kiarash Shamardani, Pamelyn J. Woo OpenAlex Published psilocybin PharmacologyMechanism of ActionReceptor Pharmacology Animal Study More
Select for export The emotional architecture of the psychedelic brain. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.tics.2025.07.006 PubMed 40830011 Copy citation Copy BibTeX Trends in cognitive sciences 2025-10-31 Moujaes F, Rieser NM, Belinger L, Herdener M, Zahid Z, Preller KH PubMed Published psilocybin DepressionChronic PainNeuroplasticity Review Article More
Select for export The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pbb.2025.174087 PubMed 40849009 Copy citation Copy BibTeX Pharmacology, biochemistry, and behavior 2025-10-31 Rahmani S, Crupi R, Riley AL, Davidson T PubMed Published psilocybin DepressionAnxietyPTSD Other More
Select for export Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applications Abstract available at the source but not redistributed here. Read at source. Details DOI 10.54033/cadpedv22n12-345 Copy citation Copy BibTeX Caderno Pedagógico 2025-10-30 André Leão Dantas, Lara Moreira Jalles Milani, Saulo Gabriel Moreira Falci, João Américo da Silveira, Cristina Pereira Isolan, Lia Dietrich OpenAlex Published psilocybin Chronic PainNeuroplasticityPharmacology Randomized Controlled Trial More
Select for export “It Fueled the Fire to Who I Am Now”: Exploring Motivations for Microdosing Psychedelics Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/00220426251395178 Copy citation Copy BibTeX Journal of Drug Issues 2025-10-30 Blake Beaton OpenAlex Published psilocybin DepressionAnxietyAddiction Other More
Select for export Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41398-025-03654-3 PubMed 41173871 Copy citation Copy BibTeX Unknown journal 2025-10-30 d'Andrea G, Chiappini S, Ciavoni L, Tucci R, Martino F, Semeraro FM Europe PMC Published psilocybin DepressionAnxietyBrain Imaging Systematic Review More
Select for export A Randomized, Double-Blind, Placebo-Controlled Mechanistic Study to Assess a Single Oral Dose of CYB003 in Participants With Major Depressive Disorder (MDD) and Moderate to Severe Anxiety Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-10-29 Ohio State University ClinicalTrials.gov CLINICAL TRIAL psilocybinpsilocin DepressionAnxietyNeuroplasticity Clinical Trial More
Select for export A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)? Abstract available at the source but not redistributed here. Read at source. Details Copy citation Copy BibTeX ClinicalTrials.gov 2025-10-28 Anna Rose Childress, Ph.D. ClinicalTrials.gov CLINICAL TRIAL psilocybin DepressionAddictionOCD Clinical Trial More
Select for export Psilocybin's effects on obsessive-compulsive behaviors: A systematic review of preclinical and clinical evidence Abstract available at the source but not redistributed here. Read at source. Details DOI 10.61373/pp025i.0044 Copy citation Copy BibTeX Psychedelics. 2025-10-27 James J Gattuso, Bilgenur Bezcioglu, Carey Wilson, Kato Havaux, Anthony J. Hannan, Thibault Renoir OpenAlex Published psilocybinpsilocin DepressionAnxietyOCD Randomized Controlled Trial More
Select for export Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1186/s40814-025-01706-5 PubMed 41152967 Copy citation Copy BibTeX Pilot and Feasibility Studies 2025-10-27 Candice Richardson, Cindy Chan, Emily Macgregor, Crystal Hare, Breffni Hannon, SarahRose Black OpenAlex Published psilocybin Chronic PainClinical TrialRandomized Controlled Trial Randomized Controlled Trial More
Select for export Provider perspectives on challenges in treatment during psychedelic therapy No abstract availability was recorded for this entry. Details DOI 10.1007/s00213-025-06907-7 PubMed 41139739 Copy citation Copy BibTeX Psychopharmacology 2025-10-26 David A. Bender, Sandeep M. Nayak, Joshua S. Siegel, David J. Hellerstein, Barış Erçal, Eric J. Lenze OpenAlex Published psilocybin Chronic PainClinical TrialToxicity Clinical Trial More
Select for export A Systematic Review and Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Use Disorder. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.3390/healthcare13212668 PubMed 41228035 Copy citation Copy BibTeX Unknown journal 2025-10-22 Keighley EE, Abo Hamza E, Bedewy DA, Nalla S, Moustafa AA. Europe PMC Published psilocybin AddictionClinical TrialMeta-Analysis Meta-Analysis More
Select for export Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.pnpbp.2025.111541 PubMed 41138900 Copy citation Copy BibTeX Unknown journal 2025-10-22 Bukovsky D, Amaev A, Song J, Kyte S, Carmona-Torres E, Ueno F Europe PMC Published psilocybin DepressionAnxietyAddiction Systematic Review More
Select for export Novel Psilocin Derivatives as Serotonergic Psychedelic Agents for Treating CNS Disorders. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/acsmedchemlett.5c00608 PubMed 41256997 Copy citation Copy BibTeX Unknown journal 2025-10-21 Sabnis RW. Europe PMC Published psilocin General Other More
Select for export Psychedelics and time: Exploring altered temporal perception and its implications for consciousness, neuroscience, and therapy Abstract available at the source but not redistributed here. Read at source. Details DOI 10.61373/pp025p.0041 Copy citation Copy BibTeX Psychedelics. 2025-10-20 Pu Jiang, Cong Lin, Xiaohui Wang OpenAlex Published psilocybin DepressionAnxietyPTSD Other More
Select for export Landscape analysis of pre-registered clinical trials involving classical psychedelics. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811251371690 PubMed 41121524 Copy citation Copy BibTeX Unknown journal 2025-10-20 Uyar A, Forbrich L, Lueken U, Evens R. Europe PMC Published psilocybin Clinical TrialReview Article Clinical Trial More
Select for export Is there more to magic mushrooms than psilocybin? Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1021/cen-10322-feature2 Copy citation Copy BibTeX C&EN Global Enterprise 2025-10-19 special to C EN Mara Johnson-Groh OpenAlex Published psilocybinpsilocin DepressionAddictionOCD Clinical Trial More
Select for export The THRIVE Model of Psychedelic Integration: A Holistic Framework Bridging Indigenous Knowledge and Evidence-Based Practice No abstract availability was recorded for this entry. Details DOI 10.1007/s40501-025-00368-7 Copy citation Copy BibTeX Current Treatment Options in Psychiatry 2025-10-19 Ashvind N. Singh, Glauber Loures de Assis OpenAlex Published psilocybin General Other More
Select for export Simulated 5-HT2A receptor activation accounts for the high complexity of brain activity during psychedelic states Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1101/2025.10.20.683366 Copy citation Copy BibTeX bioRxiv 2025-10-19 Martin HM, Cofre R, Destexhe A. bioRxiv PREPRINT (not peer reviewed) psilocybin Brain ImagingMechanism of ActionReceptor Pharmacology Other More
